{"nctId":"NCT00556478","briefTitle":"Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation","startDateStruct":{"date":"2007-10"},"conditions":["Premature Ejaculation"],"count":256,"armGroups":[{"label":"Double-Blind Active","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: PSD502, contains a mixture of lidocaine and prilocaine"]},{"label":"Double-Blind Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Open Label Phase","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: PSD502, contains a mixture of lidocaine and prilocaine"]}],"interventions":[{"name":"PSD502, contains a mixture of lidocaine and prilocaine","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Willing and able to provide written informed consent.\n* Male and aged 18 years and over.\n* Diagnosed with PE according to DMS-IV criteria and ISSM definition\n* Diagnosed with lifelong PE\n* Acceptable response to Baseline PEP\n* Subject must be in a stable heterosexual and monogamous relationship and the partner must provide consent\n* Acceptable sexual encounters in the Baseline period.\n\nExclusion Criteria:\n\n* Subject, or his sexual partner, has received an investigational (non-registered) drug within 30 days of Screening.\n* Subject has erectile dysfunction\n* The subject, or his sexual partner, has a physical or psychological condition that would prevent them from undertaking the study procedures, including, but not limited to, the following:\n\n  * Urological disease\n  * Ongoing significant psychiatric disorder not controlled by medication.\n* Subject has safety testing abnormalities at the Screening Visit\n* Subjects taking excluded medications or receiving any treatment for PE\n* Subject, or his sexual partner, has a current history of alcohol or drug abuse,\n* The subject, or his sexual partner, is unlikely to understand or be able to comply with study procedures, for whatever reasons.\n* Subject, or his sexual partner, has known drug sensitivity to amide-type local anesthetics.\n* Subjects with pregnant partners\n* Subject with sexual partners of child-bearing potential and not using appropriate contraception\n* Subject, or his sexual partner, has a history of Glucose-6-Phosphate Dehydrogenase (G-6-PD) deficiency or use of medications that would increase susceptibility to methemoglobinemia (e.g. anti-malarial agents).","healthyVolunteers":false,"sex":"MALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Intravaginal Ejaculatory Latency Time (IELT): Change From Baseline to During 3 Month Double Blind-treatment","description":"To evaluate efficacy of treatment with PSD502 compared with placebo in subjects with PE as measured by:\n\n• change in mean IELT from baseline to during the 3 month double-blind treatment\n\nResults provide are ratio (over the 3 months/baseline).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.607","spread":null},{"groupId":"OG001","value":"1.505","spread":null}]}]}]},{"type":"PRIMARY","title":"Index of Premature Ejaculation (IPE): Change From Baseline to End of Month 3","description":"To Evaluate Efficacy of Treatment With PSD502 Compared With Placebo in Subjects With PE as measured by:\n\n• changes in all 3 IPE domains from baseline to month 3\n\nEjaculatory control scores range from 4 to 20 with a higher score indicating greater ejaculatory control Sexual satisfaction scores range from 4 to 20 with a higher score indicating greater sexual satisfaction Distress scores range from 2 to 10 with a higher score indicating less distress","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":null},{"groupId":"OG001","value":"2.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":null},{"groupId":"OG001","value":"2.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":null},{"groupId":"OG001","value":"0.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Mean Intravaginal Ejaculatory Latency Time (IELT) > 1 Minute and >2 Minutes During the 3 Months of Double-blind Treatment","description":"Percentage of subjects with mean IELT \\> 1 minute and \\>2 minutes during the 3 months of double-blind treatment as measured by the proportion of subjects","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80.2","spread":null},{"groupId":"OG001","value":"37.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57.5","spread":null},{"groupId":"OG001","value":"14.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Mean Intravaginal Ejaculatory Latency Time (IELT) From Baseline to Month 3","description":"Summary of mean IELT at Baseline and at month 3 during double-blind treatment","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"140.964","spread":"463.97"},{"groupId":"OG001","value":"49.615","spread":"91.75"}]}]}]},{"type":"SECONDARY","title":"Change in the Index of Premature Ejaculation (IPE) Domains of Ejaculatory Control, Distress and Sexual Satisfaction From Baseline to Month 1","description":"Change in the IPE domains of ejaculatory control, distress and sexual satisfaction from Baseline to month 1.\n\nEjaculatory control scores range from 4 to 20 with a higher score indicating greater ejaculatory control Sexual satisfaction scores range from 4 to 20 with a higher score indicating greater sexual satisfaction Distress scores range from 2 to 10 with a higher score indicating less distress","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.7","spread":"5.92"},{"groupId":"OG001","value":"1.3","spread":"2.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"2.64"},{"groupId":"OG001","value":"0.6","spread":"1.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.1","spread":"5.86"},{"groupId":"OG001","value":"1.8","spread":"3.54"}]}]}]},{"type":"SECONDARY","title":"Subject PEP at Month 1","description":"Scores for perceived control over ejaculation, personal distress related to ejaculation, satisfaction with sexual intercourse and interpersonal difficulty related to ejaculation based on the subject PEP at month 1. Percentage of subjects with at least a 1 point category improvement in subject PEP domain scores at month 1.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.6","spread":null},{"groupId":"OG001","value":"23.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"63.4","spread":null},{"groupId":"OG001","value":"27.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62.7","spread":null},{"groupId":"OG001","value":"33.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.0","spread":null},{"groupId":"OG001","value":"51.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in the Index of Premature Ejaculation (IPE) Domains of Ejaculatory Control, Distress and Sexual Satisfaction From Baseline to Month 2","description":"Change in the IPE domains of ejaculatory control, distress and sexual satisfaction from Baseline to month 2\n\nEjaculatory control scores range from 4 to 20 with a higher score indicating greater ejaculatory control Sexual satisfaction scores range from 4 to 20 with a higher score indicating greater sexual satisfaction Distress scores range from 2 to 10 with a higher score indicating less distress","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.5","spread":"6.06"},{"groupId":"OG001","value":"1.4","spread":"3.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"6.19"},{"groupId":"OG001","value":"1.3","spread":"3.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.9","spread":"3.00"},{"groupId":"OG001","value":"0.7","spread":"1.85"}]}]}]},{"type":"SECONDARY","title":"Subject Premature Ejaculation Profile (PEP) at Month 2","description":"Scores for perceived control over ejaculation, personal distress related to ejaculation, satisfaction with sexual intercourse and interpersonal difficulty related to ejaculation based on the subject PEP at month 2. Proportion of subjects with at least a 1 point category improvement in subject PEP domain scores from baseline to month 2.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67.5","spread":null},{"groupId":"OG001","value":"24.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.1","spread":null},{"groupId":"OG001","value":"33.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.4","spread":null},{"groupId":"OG001","value":"27.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.8","spread":null},{"groupId":"OG001","value":"42.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Subject Premature Ejaculation Profile (PEP) at Month 3","description":"Scores for perceived control over ejaculation, personal distress related to ejaculation, satisfaction with sexual intercourse and interpersonal difficulty related to ejaculation based on the subject PEP at month 3. Proportion of subjects with at least a 1 point category improvement in subject PEP domain scores from baseline to month 3.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":null},{"groupId":"OG001","value":"24.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.9","spread":null},{"groupId":"OG001","value":"36.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.7","spread":null},{"groupId":"OG001","value":"36.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.6","spread":null},{"groupId":"OG001","value":"59.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Partner Premature Ejaculation Profile (PEP) at Month 3","description":"Scores for perceived control over ejaculation, personal distress related to ejaculation, satisfaction with sexual intercourse and interpersonal difficulty related to ejaculation based on the partner PEP at month 3. Proportion of partners with at least a 1 point category improvement in partner PEP domain scores from baseline to month 3.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68.9","spread":null},{"groupId":"OG001","value":"40.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.9","spread":null},{"groupId":"OG001","value":"50.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62.8","spread":null},{"groupId":"OG001","value":"32.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.9","spread":null},{"groupId":"OG001","value":"50.0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":167},"commonTop":["Erectile dysfunction"]}}}